Royalty Pharma PLC: “I like it, and I’m going to stick with it. It’s not big, but it’s not bad.”
Tellurian Inc: “It’s at $2, and stocks stop at $0. They don’t go to minus $2. So, I’m okay with Tellurian.”
Zoetis Inc: “I think the stock is now undervalued. … It’s a buy.”
Industrial outdoor storage in Elgin, Illinois. Courtesy of Alterra IOS A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. Sign up to […]
Read More
Shironosov | Istock | Getty Images A version of this article appeared in CNBC’s Inside Alts newsletter, a guide to the fast-growing world of alternative investments, from private equity and private credit to hedge funds and venture capital. Sign up to receive future editions, straight to your inbox. Investments in alternatives are expected to top $32 trillion […]
Read More
The logo of McDonald’s is seen in Los Angeles, California. Lucy Nicholson | Reuters McDonald’s is expected to report its third-quarter earnings before the bell on Wednesday. Here’s what Wall Street analysts surveyed by LSEG are expecting the company to report: Earnings per share: $3.33 expected Revenue: $7.1 billion expected The fast-food giant, often seen as […]
Read More
